ShadowBuys
Sign inJoin for free
Committee overlap: HELP

Sen. Alan Armstrong bought AbbVie (ABBV)

Sen. Alan Armstrong (R-OK) · $15K–$50K · traded Mar 27, 2026

Why this is a committee overlap

Armstrong is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. AbbVie is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Bought
Amount
$15K–$50K
Owner
The member
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026
Days to disclose
116 (after the 45-day deadline)
Asset type
Stock
As filed
AbbVie Inc. Common Stock
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Armstrong's tradesAll Congress trades in ABBV

Other trades in this filing

All of Armstrong's trades →

Recent Congress trades in ABBV

Company context for ABBV

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ABBVFinancial report·SEC EDGAR

    ABBV: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 3, 2026, 1:43 PM ESTEvent / period: Sep 30, 2026Original source ↗
  2. ABBVCompany announcement·SEC EDGAR

    ABBV: Leadership change

    Filed 8-K for an event or period dated 2026-10-28. Leadership change.

    Public: Nov 2, 2026, 4:05 PM ESTEvent / period: Oct 28, 2026Original source ↗
  3. ABBVCompany announcement·SEC EDGAR

    ABBV: Financial results

    Filed 8-K for an event or period dated 2026-10-30. Financial results.

    Public: Oct 30, 2026, 7:51 AM EDTEvent / period: Oct 30, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.